<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T18:29:37Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/66110" metadataPrefix="mods">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/66110</identifier><datestamp>2025-03-03T07:19:57Z</datestamp><setSpec>com_10324_1181</setSpec><setSpec>com_10324_931</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_1387</setSpec></header><metadata><mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:namePart>Ochoa, Juan P.</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Lopes, Luis R.</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Perez Barbeito, Marlene</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Cazón Varela, Laura</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Torre Carpente, Maria M. de la</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Sonicheva‐Paterson, Natalia</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Uña Iglesias, David de</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Quinn, Ellen</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Kuzmina‐Krutetskaya, Svetlana</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Garrote Adrados, José Antonio</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Elliott, Perry M.</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Monserrat, Lorenzo</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2024-02-09T20:01:37Z</mods:dateAvailable>
</mods:extension>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2024-02-09T20:01:37Z</mods:dateAccessioned>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2020</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="citation">Clin Genet. 2020 Jul;98(1):86-90. doi: 10.1111/cge.13759. Epub 2020 May 11. PMID: 32335906.</mods:identifier>
<mods:identifier type="issn">0009-9163</mods:identifier>
<mods:identifier type="uri">https://uvadoc.uva.es/handle/10324/66110</mods:identifier>
<mods:identifier type="doi">10.1111/cge.13759</mods:identifier>
<mods:identifier type="publicationfirstpage">86</mods:identifier>
<mods:identifier type="publicationissue">1</mods:identifier>
<mods:identifier type="publicationlastpage">90</mods:identifier>
<mods:identifier type="publicationtitle">Clinical Genetics</mods:identifier>
<mods:identifier type="publicationvolume">98</mods:identifier>
<mods:identifier type="essn">1399-0004</mods:identifier>
<mods:abstract>Despite new strategies, such as evaluating deep intronic variants and new genes in&#xd;
whole-genome-sequencing studies, the diagnostic yield of genetic testing in hypertrophic&#xd;
cardiomyopathy (HCM) is still around 50%. FHOD3 has emerged as a novel&#xd;
disease-causing gene for this phenotype, but the relevance and clinical implication of&#xd;
copy-number variations (CNVs) have not been determined. In this study, CNVs were&#xd;
evaluated using a comparative depth-of-coverage strategy by next-generation&#xd;
sequencing (NGS) in 5493 HCM probands and 2973 disease-controls. We detected&#xd;
three symmetrical deletions in FHOD3 that involved exons 15 and 16 in three HCM&#xd;
families (no CNVs were detected in the control group). These exons are part of the&#xd;
diaphanous inhibitory domain of FHOD3 protein, considered a cluster of mutations&#xd;
for HCM. The clinical characteristics of the affected carriers were consistent with&#xd;
those reported in FHOD3 in previous studies. This study highlights the importance of&#xd;
performing CNV analysis systematically in NGS genetic testing panels for HCM, and&#xd;
reinforces the relevance of the FHOD3 gene in the disease.</mods:abstract>
<mods:language>
<mods:languageTerm>spa</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">info:eu-repo/semantics/openAccess</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">John Wiley &amp; Sons Ltd</mods:accessCondition>
<mods:subject>
<mods:topic>Cardiología</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Genética</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Miocardiopatía Hipertrófica Familiar</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>next-generation sequencing</mods:topic>
</mods:subject>
<mods:titleInfo>
<mods:title>Deletions of specific exons of FHOD3 detected by next‐generation sequencing are associated with hypertrophic cardiomyopathy</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/article</mods:genre>
</mods:mods></metadata></record></GetRecord></OAI-PMH>